Skip to main content
. 2017 Oct 25;8:2020. doi: 10.3389/fmicb.2017.02020

Figure 5.

Figure 5

Adenylate-cyclase activity regulates the entry of T. cruzi into DC-PBMC. DC-PBMC were treated for 30 min separately either with or without SQ 22536 (20 μM) and exposed to 5:1 trypomastigotes of T. cruzi (Y strain) during 18 h. Inhibition of adenylate-cyclase decreases T. cruzi infection (A). Number of infected DC-PBMC with nine amastigotes per cell decreased with the treatment (B). Results are the mean ± standard error for duplicate determinations, with five (A) and six (B) blood donors in each experiment. Means not sharing letter are significantly different (P < 0.05, one-way ANOVA with Tukey's post-test).